METTL14 and colorectal carcinoma: Low expression of METTL14 in CRC resulted in decreased m6A modification level, which in turn reduced the recognition and binding of pri-miR-17 by YTHDC2, promoted the stability of pri-miR-17 mRNA, and increased the expression of miR-17-5p.